{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:09Z","timestamp":1792176009916,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.msard.2020.102462","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T02:32:57Z","timestamp":1598495577000},"page":"102462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Urinary tract infection in patients with multiple sclerosis: An overview"],"prefix":"10.1016","volume":"46","author":[{"given":"Washigton Luiz Gomes de","family":"Medeiros Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Cesar","family":"Demore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Peres","family":"Mazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Fellipe Nascimento","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Fiuza","family":"Parolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Rogerio Werka","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius Magno","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102462_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/antibiotics7010006","article-title":"Reevaluation of the acute cystitis symptom score, a self-reporting questionnaire. Part, I. Development, diagnosis and differential diagnosis","volume":"7","author":"Alidjanov","year":"2018","journal-title":"Antibiotics"},{"key":"10.1016\/j.msard.2020.102462_bib0002","first-page":"43","article-title":"Reevaluation of the acute cystitis symptom score, a self-reporting questionnaire. Part II. Patient-Reported. Outcome","volume":"7","author":"Alidjanov","year":"2018","journal-title":"Assess. Antibiot."},{"key":"10.1016\/j.msard.2020.102462_bib0003","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2020.102462_bib0004","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/IAI.00255-13","article-title":"Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder","volume":"81","author":"Balsara","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.msard.2020.102462_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/21556660.2020.1721507","article-title":"Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations","volume":"9","author":"Caniba\u00f1o","year":"2020","journal-title":"J. Drug Assess."},{"issue":"2","key":"10.1016\/j.msard.2020.102462_bib0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S0101-28002012000200011","article-title":"Use of vaccines for prophylaxis of urinary tract infections","volume":"34","author":"Carraro-Eduardo","year":"2012","journal-title":"Brazil. J. Nephrol."},{"issue":"10","key":"10.1016\/j.msard.2020.102462_bib0007","doi-asserted-by":"crossref","first-page":"474","DOI":"10.12968\/ijpn.2017.23.10.474","article-title":"Preserving the independence of people living with multiple sclerosis towards the end of life","volume":"23","author":"Costello","year":"2012","journal-title":"Int. J. Palliat. Nurs."},{"key":"10.1016\/j.msard.2020.102462_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/nau.23713","article-title":"The ability of prior urinary cultures results to predict future culture results in neurogenic bladder patients.","author":"Clark","year":"2018","journal-title":"Neurourology and Urodynamics"},{"key":"10.1016\/j.msard.2020.102462_bib0045","doi-asserted-by":"crossref","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: Review of the literature and proposal of management guidelines.","author":"de S\u00e8ze","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2020.102462_bib0009","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.juro.2011.02.002","article-title":"Urinary diversion \/ reconstruction for cases of catheter intolerant secondary progressive multiple sclerosis with refractory urinary symptoms","volume":"185","author":"Delong","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.msard.2020.102462_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2490-4-4","article-title":"The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy","volume":"4","author":"Devill\u00e9","year":"2004","journal-title":"BMC Urol."},{"key":"10.1016\/j.msard.2020.102462_bib0011","unstructured":"EAU Guidelines.Edn. presented at the European Association of Urology Annual Congress Amsterdam the Netherlands 2020. ISBN 978-94-92671-07-3."},{"key":"10.1016\/j.msard.2020.102462_bib0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.msard.2019.06.038","article-title":"The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse","volume":"35","author":"Fitzgerald","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102462_bib0013","first-page":"470","article-title":"A UK consensus on the management of the bladder in multiple sclerosis","volume":"80","author":"Fowler","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2020.102462_bib0014","doi-asserted-by":"crossref","unstructured":"Gallien P, Amarenco G, Benoit N, Bonniaud V, Donz\u00e9 C, Kerdraon J, et\u00a0al. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, 2014. DOI:10.1177\/1352458513517592.","DOI":"10.1177\/1352458513517592"},{"issue":"1","key":"10.1016\/j.msard.2020.102462_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0635-y","article-title":"Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study","volume":"16","author":"Gold","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2020.102462_bib0016","article-title":"Multiple cause of death analysis in multiple sclerosis","author":"Harding","year":"2020","journal-title":"Neurol. J."},{"key":"10.1016\/j.msard.2020.102462_bib0018","article-title":"Urinary Dysfunction and Multiple Sclerosis: A Clinical Practice Guideline for Professionals developed","author":"Holland","year":"2016","journal-title":"Natl. Mult. Scler. Soc."},{"issue":"Oct 15","key":"10.1016\/j.msard.2020.102462_bib0017","first-page":"1","article-title":"Bladder dysfunction in multiple sclerosis","author":"Holland","year":"2012","journal-title":"Prof. Resour. Cent. Natl. Mult. Scler. Soc."},{"key":"10.1016\/j.msard.2020.102462_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00457","article-title":"The soluble form of toll-like receptor 2 is elevated in serum of multiple sclerosis patients: a novel potential disease biomarker","volume":"9.","author":"Hossain","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2020.102462_bib0020","doi-asserted-by":"crossref","unstructured":"Jahromi MS, Mure A, Gomez CS. UTIs in patients with neurogenic bladder2014. DOI:10.1007\/s11934-014-0433-2.","DOI":"10.1007\/s11934-014-0433-2"},{"issue":"9","key":"10.1016\/j.msard.2020.102462_bib0021","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00415-015-7796-2","article-title":"Epidemiology of multiple sclerosis: Results from a large observational study in the UK","volume":"262","author":"Jick","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2020.102462_bib0022","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/00325481.2015.1000229","article-title":"Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis","volume":"127","author":"Kantor","year":"2015","journal-title":"Postgrad. Med."},{"issue":"102051","key":"10.1016\/j.msard.2020.102462_bib0043","article-title":"The epidemiology of comorbidities among MS patients in northeastern Poland.","volume":"41","author":"Kapica-Topczewska","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"3","key":"10.1016\/j.msard.2020.102462_bib0023","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1468-1331.2012.03833.x","article-title":"Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem","volume":"20","author":"Maghzi","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102462_bib0024","first-page":"57","article-title":"Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large university hospital","volume":"3","author":"Mahadeva","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2020.102462_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nau.21003","article-title":"Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database","volume":"30","author":"Manack","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.msard.2020.102462_bib0026","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.0000000000000753","article-title":"Dramatically changing rates and reasons for hospitalization in multiple sclerosis","volume":"83","author":"Marrie","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2020.102462_bib0027","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/10790268.2009.11754562","article-title":"Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization","volume":"32","author":"Massa","year":"2009","journal-title":"J. Spinal. Cord. Med."},{"key":"10.1016\/j.msard.2020.102462_bib0028","article-title":"Factors affecting continuation of clean intermittent catheterisation in people with multiple sclerosis: Results of the COSMOS mixed-methods study","author":"McClurg","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2020.102462_bib0029","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5539\/gjhs.v8n4p253","article-title":"Association between urinary symptoms and urinary tract infection in patients with multiple sclerosis","volume":"8","author":"Nikseresht","year":"2015","journal-title":"Glob. J. Health Sci."},{"issue":"September","key":"10.1016\/j.msard.2020.102462_bib0030","first-page":"1","article-title":"Screening for urinary tract colonization prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm","volume":"407","author":"O'Herlihy","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.msard.2020.102462_bib0031","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458516633903","article-title":"Urinary tract infections in multiple sclerosis","volume":"22","author":"Ph\u00e9","year":"2016","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2020.102462_bib0032","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/nau.23173","article-title":"Open-label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis","volume":"36","author":"Ph\u00e9","year":"2017","journal-title":"Neurourol. Urodyn."},{"issue":"5","key":"10.1016\/j.msard.2020.102462_bib0033","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/00207454.2014.937002","article-title":"Demographic characteristics of MS patients in Poland's upper Silesia region","volume":"125","author":"Pierzchala","year":"2014","journal-title":"Int. J. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2020.102462_bib0034","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1468-1331.2012.03806.x","article-title":"Testing for urinary tract colonization before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation","volume":"20","author":"Rakusa","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"May","key":"10.1016\/j.msard.2020.102462_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.msard.2017.08.009","article-title":"Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: should we do it?","volume":"18","author":"Rouzaud","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"Dec(10)","key":"10.1016\/j.msard.2020.102462_bib0036","first-page":"1010","article-title":"Clinical and urodynamic risk factors of recurrent urinary tract infections in patients with multiple sclerosis","volume":"72","author":"Salinas-Casado","year":"2019","journal-title":"Arch. Esp. Urol."},{"issue":"7","key":"10.1016\/j.msard.2020.102462_bib0037","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.disamonth.2013.03.013","article-title":"The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients","volume":"59","author":"Sand","year":"2013","journal-title":"Dis.-a-Month [Internet]"},{"issue":"1","key":"10.1016\/j.msard.2020.102462_bib0038","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sc.2014.154","article-title":"Emergence and prevention measures for multidrug resistant Pseudomonas aeruginosa in catheter-associated urinary tract infection in spinal cord injury patients","volume":"53","author":"Shigemura","year":"2015","journal-title":"Spinal Cord"},{"key":"10.1016\/j.msard.2020.102462_bib0039","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00415-016-8212-2","article-title":"Neurogenic lower urinary tract dysfunction: evaluation and management","volume":"263","author":"Tudor","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2020.102462_bib0040","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1177\/1352458510387183","article-title":"A patient with established primary progressive multiple sclerosis transitions to \u2018secondary\u2019 relapsing-remitting disease course following a fulminant demyelinating episode","volume":"17","author":"Tutuncu","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2020.102462_bib0041","article-title":"Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study","author":"Wijnands","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry, jnnp\u20132017\u2013317493."},{"issue":"4","key":"10.1016\/j.msard.2020.102462_bib0042","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2016.21","article-title":"Disease-modifying therapies and infectious risks in multiple sclerosis","volume":"12","author":"Winkelmann","year":"2016","journal-title":"Nat. Rev. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:58:39Z","timestamp":1761901119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482030537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":44,"alternative-id":["S221103482030537X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102462","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary tract infection in patients with multiple sclerosis: An overview","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102462"}}